Stay updated on Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.

Latest updates to the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page
- Check4 days agoChange DetectedThe footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision entry appears in the record history for v3.7.0, replacing the previous v3.6.6. This reflects an updated version of the page's documentation.SummaryDifference0.1%

- Check46 days agoChange DetectedA new version entry (version 26) was added on 2026-08-27 with an update to the Study Status. The page revision was updated to v3.6.6 on 2026-08-28.SummaryDifference0.4%

- Check67 days agoChange DetectedThe page history now shows a new site revision (v3.6.5) replacing the previous (v3.6.4), indicating a software update to the ClinicalTrials.gov history interface.SummaryDifference0.2%

- Check82 days agoChange DetectedA new platform revision label, v3.6.4, was added to the history, replacing the previous v3.6.3. This reflects a software release for the page and does not modify study records or displayed content.SummaryDifference0.1%

- Check103 days agoChange DetectedRevision: v3.6.3 was added to the page history and Revision: v3.6.2 was removed, reflecting a small system update to the site’s version labeling rather than changes to the study record.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.